MAP2K1 and hepatocellular carcinoma: In hepatocellular carcinoma (HCC), Pyk2 overexpression increases MEK1/2 (mitogen‐activated protein kinase 1/2) phosphorylation, promotes the activation of c‐Src and ERK1/2, induces cancer cell proliferation (Sun et al., 2008).